Drug Chatter -- Tracking biopharma stock chatter

💊 Get Daily Updates on Generic Entry, Litigation, Biosimilars, and More…

Profile for Alnylam Pharmaceuticals, Inc. (ALNY)

« Back to company index

ALNY Chatter Timeline

Stock Ticker for ALNY

Most Active Tweeters for ALNY

UserTweets
@MarcJacksonLA 5
@Steve_382 4
@equity_newswire 3
@Estimize 3
@RNAiAnalyst 2

Recent Tweets for ALNY

RNAiAnalyst @RNAiAnalyst
$ALNY RE Oxlumo (hyperoxaluria) clin update (-->last week). https://t.co/w2s2PZ8qcD A bit worrisome, no real diff… https://t.co/p5pcpcWiuS
May 7th 2021, 11:05am
CompoundNovice @CompoundNovice
@gamechangercap I believe the expansion of RNAi outside of the liver is just getting started. $ALNY is expanding to… https://t.co/ukM7i6Kpq8
May 5th 2021, 10:05pm
Steve_382 @Steve_382
$NVS $ALNY Another study that seems to be working toward using Inclisiran in the general population. https://t.co/qbCcIs2SLj
May 5th 2021, 3:05pm
equity_newswire @equity_newswire
$ALNY Alnylam to Webcast Presentations at Upcoming May Investor Conferences https://t.co/DmVkpyztfV
May 5th 2021, 4:05am
Steve_382 @Steve_382
May regret this, but I added some $ALNY at $130.72.
May 4th 2021, 4:05pm
MarcJacksonLA @MarcJacksonLA
$ALNY Initial results of Phase 3 trial of Kumasi ran in kids are promising https://t.co/V8SppNdOp8 via @contempeds
May 4th 2021, 2:05pm
Ba4Saso @Ba4Saso
$ALNY waiting for buy signal https://t.co/aIiFGAYwsZ
May 4th 2021, 1:05pm
moneymessage_ @moneymessage_
$ALNY - Alnylam reports positive early Oxlumo data in rare kidney disorder https://t.co/VzhMNRSrcZ
May 3rd 2021, 4:05pm
Steve_382 @Steve_382
RT @MarcJacksonLA: $ALNY Alnylam provides long-term look at Oxlumo, aiming to further carve out stake in PH1 market - https://t.co/T8nGcsmd…
May 3rd 2021, 3:05pm
MarcJacksonLA @MarcJacksonLA
$ALNY Alnylam provides long-term look at Oxlumo, aiming to further carve out stake in PH1 market - https://t.co/T8nGcsmdR7
May 3rd 2021, 3:05pm
equity_newswire @equity_newswire
$ALNY Alnylam Announces Positive Early Results on Clinical Outcome Measures from ILLUMINATE-A Phase 3 Study of OXLU… https://t.co/p3G96aPgJm
May 3rd 2021, 2:05pm
MarcJacksonLA @MarcJacksonLA
$ALNY Alnylam Announces Positive Early Results on Clinical Outcome Measures from ILLUMINATE-A Phase 3 Study of OXLU… https://t.co/ZfQz5otpNG
May 3rd 2021, 1:05pm
MarcJacksonLA @MarcJacksonLA
$ALNY Evercore Maintains Buy Rating On Alnylam Pharma, $175 PT https://t.co/K5Z443kfMp
May 3rd 2021, 1:05pm
Briefingcom @Briefingcom
$ALNY: Alnylam Pharma announces "positive" early results on clinical outcome measures from the 12-month analysis of… https://t.co/bIn2nVV60k
May 3rd 2021, 1:05pm
Jarvis_Alerts @Jarvis_Alerts
$ALNY [Alnylam Pharmaceuticals]: Morgan Stanley Maintains Overweight Lowers Price Target $206 --> 205 https://t.co/9ABRYIwRGj
May 3rd 2021, 12:05pm
newsfilterio @newsfilterio
Alnylam reports positive early Oxlumo data in rare kidney disorder $ALNY https://t.co/Bhc8QCVUSl
May 3rd 2021, 11:05am
glitchbotio @glitchbotio
RT @MarketCurrents: $ALNY - Alnylam reports positive early Oxlumo data in rare kidney disorder https://t.co/EZ55UWFDiS
May 3rd 2021, 11:05am
MarketCurrents @MarketCurrents
$ALNY - Alnylam reports positive early Oxlumo data in rare kidney disorder https://t.co/EZ55UWFDiS
May 3rd 2021, 11:05am
otcdynamics @otcdynamics
$ALNY Alnylam Announces Positive Early Results on Clinical Outcome Measures from ILLUMINATE-A Phase 3 Study of OXLU… https://t.co/5N81gubzeo
May 3rd 2021, 11:05am
sbwcws @sbwcws
Alnylam announces early results from ILLUMINATE-A trial $ALNY
May 3rd 2021, 11:05am
StckPro @StckPro
$ALNY NEW ARTICLE : Alnylam Announces Positive Early Results on Clinical Outcome Measures from ILLUMINATE-A Phase 3… https://t.co/LPNrdmulcV
May 3rd 2021, 11:05am
FlashAlert_me @FlashAlert_me
$ALNY [15s. delayed]: Issued Press Release on May 03, 07:00:00: Alnylam Announces Positive Early Results on Clinica… https://t.co/HeusebW5tn
May 3rd 2021, 11:05am
stock_titan @stock_titan
$ALNY Alnylam Announces Positive Early Results on Clinical Outcome Measures from ILLUMINATE-A Phase 3 Study of OXLU… https://t.co/PbJA9w5mF3
May 3rd 2021, 11:05am
CSIMarket @CSIMarket
$ALNY #StockMarket #AlnylamPharmaceuticals reported first quarter of 2021 Revenues on https://t.co/savSNTKlN1: In c… https://t.co/ZmUxAiOiGx
April 30th 2021, 7:04pm
Ba4Saso @Ba4Saso
$ALNY waiting for short signal https://t.co/jZNdwD2USe
April 30th 2021, 2:04pm
Piddybul @Piddybul
RT @RNAiPhD: $ALNY Blood pressure-lowering medication can prevent serious cardiovascular conditions such as strokes, heart failure and hear…
April 30th 2021, 9:04am
RNAiPhD @RNAiPhD
$ALNY Blood pressure-lowering medication can prevent serious cardiovascular conditions such as strokes, heart failu… https://t.co/e3eOpfcOZt
April 30th 2021, 8:04am
botpicks @botpicks
Should I Go Long or Short $ALNY ?
April 30th 2021, 7:04am
equity_newswire @equity_newswire
$ALNY Alnylam Pharmaceuticals Reports First Quarter 2021 Financial Results and Highlights Recent Period Activity https://t.co/6cikaslDnc
April 30th 2021, 5:04am
SU_pharma @SU_pharma
@pt117cool Hi, Mike. Are you interested in $ALNY as well? I was excited about yesterday’s conference call even though stock felled a bit.
April 30th 2021, 1:04am
Steve_382 @Steve_382
I would have thought it would take more of a drop. Perhaps the $ALNY therapy will be an option some day with 10 mm… https://t.co/Jb30nELRd2
April 30th 2021, 12:04am
EarningsAlley @EarningsAlley
Alnylam Pharmaceuticals, Inc. $ALNY held an earnings call on 4/29/2021. Here are the highlights:
April 29th 2021, 9:04pm
SiteFocusHQ @SiteFocusHQ
$ALNY Earnings Intelligence Analysis of recent earnings identified Alnylam Pharmaceuticals, Inc. business focus on… https://t.co/FOxeG8KIR1
April 29th 2021, 9:04pm
EdgarInsider @EdgarInsider
A new filing Form 10-Q [Quarterly Report] has been made at the SEC by $ALNY #AlnylamPharmaceuticals, Inc https://t.co/qJGEwFnBqV
April 29th 2021, 8:04pm
SeekingAlpha @SeekingAlpha
$ALNY - Alnylam Pharmaceuticals, Inc. (ALNY) CEO John Maraganore on Q1 2021 Results - Earnings Call Transcript.… https://t.co/L9vEyA3Ryz
April 29th 2021, 7:04pm
Quantumup1 @Quantumup1
BofA $ALNY HELIOS-B trial of vutrisiran in ATTR CM is enrolling ahead of schedule/is expected to complete enrollmen… https://t.co/w7Zeo0MRfA
April 29th 2021, 4:04pm
SeekingAlpha @SeekingAlpha
$ALNY - Alnylam Pharmaceuticals, Inc. 2021 Q1 - Results - Earnings Call Presentation. https://t.co/3xI6dNVThN #finance #markets #investing
April 29th 2021, 3:04pm
IonisDisrupts @IonisDisrupts
@Sanctuary_Bio Anything about the Justice Dept investigation? $alny
April 29th 2021, 2:04pm
Briefingcom @Briefingcom
$ALNY: Alnylam Pharma misses by $0.28, misses on revs; reaffirms FY21 revs guidance https://t.co/7QdIYxLpTx
April 29th 2021, 2:04pm
MarcJacksonLA @MarcJacksonLA
$ALNY Alnylam Pharmaceuticals Reports First Quarter 2021 Financial Results and Highlights Recent Period Activity |… https://t.co/aKicqEjDrS
April 29th 2021, 1:04pm
Prof_Oak_ @Prof_Oak_
Continued strong commercial execution and path to profitability. Have said this many times but $ALNY is the next… https://t.co/ViC5Pz7tV1
April 29th 2021, 1:04pm
Estimize @Estimize
Great work by Oppenheimer_62 who takes the win for $ALNY beating 6 other analysts and the Wall Street Consensus - https://t.co/Fw4Rn4EPp1
April 29th 2021, 12:04pm
Estimize @Estimize
$ALNY misses the Estimize EPS Consensus by 17c and beats the Estimize Revenue Consensus by $1.85M. Reports FQ1 earn… https://t.co/s4g88KDD5V
April 29th 2021, 12:04pm
Sanctuary_Bio @Sanctuary_Bio
Pretty decent $ALNY ER Sequential growth at 20%...expectations are fairly high at this valuation but 2021 targets… https://t.co/G2078TWaMG
April 29th 2021, 12:04pm
stockhoot @stockhoot
$ALNY earnings are out!! https://t.co/A8eo8sLj9t
April 29th 2021, 12:04pm
fintel_io @fintel_io
$ALNY / Alnylam Pharmaceuticals files form 8-K - Financial Statements and Exhibits, Results of Operations and Finan… https://t.co/zmbH6XZjDp
April 29th 2021, 12:04pm
EdgarInsider @EdgarInsider
A new filing Form 8-K [Press/News Current Report] has been made at the SEC by $ALNY #AlnylamPharmaceuticals, Inc https://t.co/Chc5xf5QdS
April 29th 2021, 12:04pm
glitchbotio @glitchbotio
RT @MarketCurrents: $ALNY - Alnylam Pharmaceuticals EPS misses by $0.24, beats on revenue https://t.co/xMp6jvtMMT
April 29th 2021, 12:04pm
MarketCurrents @MarketCurrents
$ALNY - Alnylam Pharmaceuticals EPS misses by $0.24, beats on revenue https://t.co/xMp6jvtMMT
April 29th 2021, 12:04pm
FlashAlert_me @FlashAlert_me
$ALNY [15s. delayed]: Issued Press Release on April 29, 08:00:00: Alnylam Pharmaceuticals Reports First Quarter 202… https://t.co/mDhToWDn4K
April 29th 2021, 12:04pm

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2021. All rights reserved.